Tpp1tm1.1Dprc
Targeted Allele Detail
|
Symbol: |
Tpp1tm1.1Dprc |
Name: |
tripeptidyl peptidase I; targeted mutation 1.1, David Pearce |
MGI ID: |
MGI:5901874 |
Synonyms: |
CLN2R207X |
Gene: |
Tpp1 Location: Chr7:105394018-105401442 bp, - strand Genetic Position: Chr7, 55.97 cM
|
Alliance: |
Tpp1tm1.1Dprc page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:241344
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129 x C57BL/6
|
|
Allele Type: |
|
Targeted (Humanized sequence, Hypomorph) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: The targeting vector is designed to insert an FRT-flanked neomycin (neo) resistance cassette downstream of exon 6 of the gene. A C to T transition was introduced in exon 6, corresponding to human amino acid 208, resulting in a nonsense mutation, R207X, commonly found in patients with late infantile Neuronal Ceroid Lipofuscinoses (NCL) or Batten disease. Flp-mediated recombination removed the FRT-flanked neo cassette.
(J:241344)
|
|
|
|
Original: |
J:241344 Geraets RD, et al., A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies. PLoS One. 2017;12(5):e0176526 |
All: |
3 reference(s) |
|